Equillium to present at the cantor fitzgerald virtual global healthcare conference

La jolla, calif.--(business wire)---- $eq--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will participate in a fireside chat presentation at the cantor fitzgerald virtual global healthcare conference, taking place september 27 – 30, 2021. bruce steel, equillium's chief executive officer, and dolca thomas m.d., equillium's executive vice president of re
EQ Ratings Summary
EQ Quant Ranking